NCT03967561

Brief Summary

This is a randomized clinical trial with the aim to evaluate the effects of two water-based aerobic training programs (walking or running in shallow pool) on type 2 diabetes control. The sample will be composed by 50 individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years, who will be randomized into water-based progressive aerobic training (PAT, n=25) and water-based non-progressive aerobic training (NPAT, n=25). Both trainings will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each). Biochemical, cardiorespiratory fitness, maximum strength, body composition and functional mobility variables, as also quality of life, sleep quality and depressive symptoms will be analyzed before and after the 12 weeks of training.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Jun 2019

Shorter than P25 for not_applicable diabetes-mellitus-type-2

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 27, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 30, 2019

Completed
11 days until next milestone

Study Start

First participant enrolled

June 10, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2019

Completed
16 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2019

Completed
Last Updated

June 4, 2019

Status Verified

June 1, 2019

Enrollment Period

5 months

First QC Date

May 27, 2019

Last Update Submit

June 2, 2019

Conditions

Keywords

ExerciseWater-based exerciseAerobic exerciseGlucose controlType 2 diabetes

Outcome Measures

Primary Outcomes (1)

  • Glycated Hemoglobin levels (HbA1c)

    Blood samples will be used to analyze glycated hemoglobin levels (%)

    Change from baseline levels of glycated hemoglobin to 12 weeks of intervention.

Secondary Outcomes (23)

  • Fasting plasma glucose

    At baseline and after a 12-week period

  • Fasting insulin

    At baseline and after a 12-week period

  • Insulin-resistance index (HOMA-IR)

    At baseline and after a 12-week period

  • Total cholesterol

    At baseline and after a 12-week period

  • High density lipoprotein

    At baseline and after a 12-week period

  • +18 more secondary outcomes

Study Arms (2)

Progressive aerobic training

EXPERIMENTAL

Water-based aerobic training performed with progression in the training variables. The intervention will be performed during 12 weeks, with 3 weekly sessions (of 50 minutes each), of walking/running in shallow pool.

Other: Progressive water-based aerobic training

Non-progressive aerobic training

EXPERIMENTAL

Water-based aerobic training performed without progression in the training variables. The intervention will be performed during 12 weeks, with 3 weekly sessions (of 50 minutes each), of walking/running in shallow pool.

Other: Non-progressive aerobic training

Interventions

The intervention will comprise walking/running in shallow pool with progression in the training variables. The training will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each).

Progressive aerobic training

The intervention will comprise walking/running in shallow pool without progression in the training variables. The training will have 12 weeks of duration with 3 weekly sessions (of 50 minutes each).

Non-progressive aerobic training

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals with type 2 diabetes, of both sexes, aged between 40 and 70 years.
  • Be under medical treatment with oral hypoglycemic agents and / or insulin;
  • Not be engaged in regular exercise (regular exercise was defined as performing any type of physical training for at least 20 minutes three or more days a week).

You may not qualify if:

  • Presence of:
  • uncontrolled hypertension;
  • autonomic neuropathy;
  • severe peripheral neuropathy;
  • proliferative diabetic retinopathy;
  • severe non-proliferative diabetic retinopathy;
  • uncompensated heart failure;
  • peripheral amputations;
  • chronic kidney failure;
  • body mass index (BMI)\> 45.0 kg/m2;
  • to have some muscle or joint impairment that prevents the performance of physical exercises safely.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor Activity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Study Officials

  • Luiz FM Kruel, phd

    Federal University of Rio Grande do Sul

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Luiz FM Kruel, phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial with two interventions in parallel.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

May 27, 2019

First Posted

May 30, 2019

Study Start

June 10, 2019

Primary Completion

October 30, 2019

Study Completion

November 15, 2019

Last Updated

June 4, 2019

Record last verified: 2019-06

Data Sharing

IPD Sharing
Will not share